Form 4: Opko Health Sells Shares of GeneDx Holdings Corp.

Opko Health, a significant shareholder of GeneDx Holdings Corp., has sold a portion of its Class A Common Stock in two transactions.

Summary

• Opko Health, Inc. sold 12,994 shares of GeneDx Holdings Corp. Class A Common Stock on August 6, 2024, at a weighted average price of $29.3541 per share.
• The shares were sold in multiple transactions with prices ranging from $29.00 to $29.75.
• On August 8, 2024, Opko Health sold an additional 100,000 shares of Class A Common Stock at a weighted average price of $31.8238 per share.
• These shares were sold in multiple transactions with prices ranging from $31.20 to $32.50.
• Following these transactions, Opko Health beneficially owns 2,871,570 shares of GeneDx Holdings Corp. Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting the sale of shares. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about transactions.

Industry Context

This Form 4 filing indicates a change in ownership of GeneDx Holdings Corp. and is a routine disclosure required by the SEC. It provides transparency into the transactions of significant shareholders.

Stakeholder Impact

• The sale of shares by Opko Health could potentially influence the market price of GeneDx Holdings Corp.
• Existing shareholders may react to the news of the sale, depending on their perception of Opko Health's motives.

Key Dates